JAAD Online
Optimizing care for atopic dermatitis patients during the COVID-19 pandemic

https://doi.org/10.1016/j.jaad.2020.05.027Get rights and content

Cited by (0)

Funding sources: None.

Conflicts of interest: Dr Alavi has consulted for AbbVie, Janssen, Leo, Galderma, Novartis, Infla Rx, and Valeant, and is an investigator for AbbVie, Novartis, Regeneron, Pfizer, Boehringer Ingelheim, Glenmark, Merck Serono, Roche, Xoma, Infla Rx, UCB, and Xenon. Dr Alavi has also received a grant from AbbVie. Dr Shi is a stock shareholder of Learn Health and has served as a consultant or investigator for or has received research funding from Sanofi/Regeneron, Eli Lilly, Dermira, Novartis, AbbVie, Sun Pharma, Pfizer, Leo, Menlo Therapeutics, Burt's Bees, GpSkin, and Skin Actives Scientific. Dr Hsiao, Ms Shah, and Ms Sachdeva have no conflicts of interest to declare.

Reprints not available from the authors.

View Abstract